KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Cash from Financing Activities (2016 - 2025)

Biogen has reported Cash from Financing Activities over the past 17 years, most recently at -$137.0 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at -$137.0 million for Q4 2025, down 1834.18% from a year ago — trailing twelve months through Dec 2025 was -$301.9 million (up 55.83% YoY), and the annual figure for FY2025 was -$301.9 million, up 55.83%.
  • Cash from Financing Activities for Q4 2025 was -$137.0 million at Biogen, down from -$130.2 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for BIIB hit a ceiling of $848.6 million in Q3 2023 and a floor of -$1.3 billion in Q3 2022.
  • Median Cash from Financing Activities over the past 5 years was -$86.8 million (2023), compared with a mean of -$233.5 million.
  • Peak annual rise in Cash from Financing Activities hit 167.78% in 2023, while the deepest fall reached 8631.08% in 2023.
  • Biogen's Cash from Financing Activities stood at $9.8 million in 2021, then tumbled by 175.51% to -$7.4 million in 2022, then plummeted by 8631.08% to -$646.1 million in 2023, then skyrocketed by 101.22% to $7.9 million in 2024, then tumbled by 1834.18% to -$137.0 million in 2025.
  • The last three reported values for Cash from Financing Activities were -$137.0 million (Q4 2025), -$130.2 million (Q3 2025), and -$11.7 million (Q2 2025) per Business Quant data.